[NRIX] QoQ Quarter Result on 30-Nov-2020 [#Q4]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
16-Feb-2021
Financial Year
2020
Quarter
30-Nov-2020 [#Q4]
Profit Trend
QoQ- -7.54%
YoY- -47.30%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
31/08/21 31/05/21 28/02/21 30/11/20 31/08/20 31/05/20 29/02/20 CAGR
Revenue 10,252 7,091 5,011 6,689 4,085 4,182 2,864 133.46%
PBT -28,958 -26,243 -24,204 -19,873 -18,517 -13,007 -12,380 75.93%
Tax -123 139 71 41 -675 -20,587 11 -
NP -28,835 -26,382 -24,275 -19,914 -18,517 7,580 -12,391 75.33%
Tax Rate - - - - - - - -
Total Cost 39,087 33,473 29,286 26,603 22,602 -3,398 15,255 86.92%
Ratio Analysis
31/08/21 31/05/21 28/02/21 30/11/20 31/08/20 31/05/20 29/02/20 CAGR
NP Margin -281.26 -372.05 -484.43 -297.71 -453.29 181.25 -432.65 -24.89%
Per Share
31/08/21 31/05/21 28/02/21 30/11/20 31/08/20 31/05/20 29/02/20 CAGR
EPS -0.65 -0.60 -0.63 -0.51 -1.09 0.22 -0.60 5.46%
EPS Diluted -0.65 -0.60 -0.63 -0.51 -1.09 0.22 -0.60 5.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.